Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Hologic Inc HOLX

Healthcare Medical Devices
Hologic, Inc. is a medical technology company primarily focused on improving women's health and well-being through early detection and treatment. The Company is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products. It operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The Diagnostics segment... see more

Recent & Breaking News (NDAQ:HOLX)

Hologic Announces FDA Approval of Aptima® CMV Quant Assay for Human Cytomegalovirus

Business Wire May 10, 2022

Hologic to Webcast Presentation at Upcoming Investor Conference

Business Wire May 4, 2022

Hologic Announces Financial Results for Second Quarter of Fiscal 2022

Business Wire April 27, 2022

American Society of Clinical Oncology (ASCO) Clinical Practice Guideline Now Includes Breast Cancer Index(TM) to Guide Decisions about Extended Endocrine Therapy

Business Wire April 25, 2022

Hologic to Announce Financial Results for the Second Quarter of Fiscal 2022 on Wednesday, April 27, 2022

Business Wire April 4, 2022

Hologic WTA Tour Swings into Action Ahead of BNP Paribas Open

Business Wire March 9, 2022

Hologic Partners With the WTA Tour in Landmark Title Sponsorship

Business Wire March 3, 2022

Hologic to Webcast Presentations at Upcoming Investor Conferences

Business Wire February 15, 2022

Hologic Announces Financial Results for First Quarter of Fiscal 2022

Business Wire February 2, 2022

Hologic Launches First-Ever National Advertising Campaign Featuring Mary J. Blige

Business Wire February 1, 2022

Hologic's Sustainability Leadership Makes Company "A Global Force for Good"

Business Wire January 24, 2022

Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2022

Business Wire January 9, 2022

Hologic to Announce Financial Results for the First Quarter of Fiscal 2022 on Wednesday, February 2, 2022

Business Wire January 5, 2022

Hologic Adds Aptima SARS-CoV-2 Assay to its Global Access Initiative in Resource-Limited Countries

Business Wire January 5, 2022

Hologic to Webcast Presentation at the 40th Annual J.P. Morgan Healthcare Conference

Business Wire December 28, 2021

Hologic Launches Panther Trax for High Volume Molecular Testing

Business Wire December 23, 2021

Hologic Presents Breast Cancer Index(TM) Data at SABCS 2021 Showing Net Benefit Predictive Value for Endocrine Therapy Continuation

Business Wire December 10, 2021

Hologic Closes on Acquisition of Bolder Surgical

Business Wire November 30, 2021

Hologic Pledges to Donate $5 Million to Improve Women's Health, STEM Education and Social Justice

Business Wire November 30, 2021

Hologic's COVID-19 Tests Detect Omicron Variant

Business Wire November 29, 2021